Letter on "Efficacy and Safety of Tenofovir Alafenamide (TAF) and Tenofovir Disoproxil Fumarate (TDF) Followed by TAF in Chronic Hepatitis B Patients of East Asian Ethnicity Following 5 Years of Treatment" [0.03%]
关于“恩曲他滨搭配恩替卡韦或拉米夫定治疗HBeAg阳性慢性乙肝感染儿童的疗效和安全性：一项随机、双盲、双模拟、3期非inferiority研究”的信件答复
Yan Liu,Liheng Wang,Li Li et al.
Yan Liu et al.
Letter: Methodological Flaws and Clinical Gaps-A Critique of TAF/TDF 5-Year Data in East Asian CHB [0.03%]
来信：方法缺陷和临床空白-对TAF/TDF在东亚CHB患者中5年数据的批评
Zhiyao Shi,XiaoKun Yang,Xixing Wang
Zhiyao Shi
Letters on "Efficacy and Safety of Tenofovir Alafenamide (TAF) and Tenofovir Disoproxil Fumarate (TDF) Followed by TAF in Chronic Hepatitis B Patients of East Asian Ethnicity Following 5 Years of Treatment." Authors' Reply [0.03%]
关于“替诺福韦阿拉芬酰胺(TAF)和富马酸替诺福韦二吡呋酯(TDF)继以TAF治疗的东亚裔慢性乙型肝炎患者五年疗效及安全性的信”作者回信
Grace Lai-Hung Wong,Edward J Gane,Wan-Long Chuang et al.
Grace Lai-Hung Wong et al.
Editorial: Predicting Hepatocellular Carcinoma Development in Chronic Hepatitis B Patients With Metabolic Dysfunction-Do Existing Scores Clear the Bar? Authors' Reply [0.03%]
编辑来信：用现有的评分预测代谢功能障碍的慢性乙肝患者肝细胞癌的发生——作者答复
Lesley A Patmore,Milan J Sonneveld
Lesley A Patmore
Research Communication: Comparative Effectiveness of Ustekinumab and Vedolizumab in the Management of Chronic Pouchitis-A Population-Based Study [0.03%]
乌司奴单抗和维多珠单抗治疗慢性回肠储袋炎疗效的比较：基于人群的研究
Saqr Alsakarneh,June Tome,Francis A Farraye et al.
Saqr Alsakarneh et al.
Introduction: Chronic pouchitis is a major therapeutic challenge in patients with ulcerative colitis following ileal pouch-anal anastomosis. Methods: ...
Prevalence of Opioid Use and Associated Healthcare Outcomes in Rome IV Irritable Bowel Syndrome in the United Kingdom [0.03%]
英国IV罗马肠易激综合征的阿片类药物使用率及相关的医疗结果
Mohsin F Butt,Vivek C Goodoory,Cho Ee Ng et al.
Mohsin F Butt et al.
Background: The United Kingdom (UK) has one of the highest worldwide opioid prescription rates per capita. International guidelines caution against the use of opioids for chronic non-malignant pain, including irritable bo...
Improving Clinical Outcomes of Encapsulated Faecal Microbiota Transplantation for Clostridioides difficile Infection Through Empirical Donor Selection and Optimised Dosing: A Quality Improvement Study [0.03%]
通过经验性供者选择和优化剂量来改善胶囊粪便微生物移植治疗艰难梭菌感染的临床结局：一项质量改进研究
Sara Ellegaard Paaske,Simon Mark Dahl Baunwall,Tone Rubak et al.
Sara Ellegaard Paaske et al.
Background: Faecal microbiota transplantation (FMT) is effective for Clostridioides difficile infection (CDI), but real-world effectiveness data are warranted to refine treatment algorithms. We previously found that FMT e...
Letter on "Telemetric Assessment and Comparison of Regional Colonic Metabolic Activity in Ambulant Healthy Individuals Using pH and Gas-Sensing Wireless Motility Capsules" [0.03%]
关于使用pH和气体传感无线胶囊测定并比较健康行走者区域结肠代谢活动的 telemetry研究报告
Xuezheng Zhu,Daquan Liao,Shiye Huang et al.
Xuezheng Zhu et al.